The Value Added Medicines Group Highlights the Importance of Access to Health during the CPhI Conference

3 October 2016

The Value Added Medicines Group a sector group of Medicines […]

Generic Medicines at the Heart of the French Public Health System

30 September 2016

Medicines for Europe strongly supports the French government campaign to […]

Generic Medicines save European Countries 100 Billion Euro per Year

28 September 2016

Lisbon, September 28, 2016 – Without the use of generic […]

Medicines for Europe and GPhA commit to supporting positive developments of the negotiations for a TTIP

23 September 2016

   Medicines for Europe and GPhA (Generic Pharmaceutical Association) are committed to […]

UN Meeting on Antimicrobial Resistance (AMR): Medicines for Europe engaged in addressing the Global Threat of AMR

22 September 2016

As a signatory of the Davos Declaration we welcome the […]

Fulfilling the Biosimilar Promise: Report Highlights Key Principles in Support of a Sustainable Market

19 September 2016

Biosimilar medicines provide a tremendous opportunity for governments throughout Europe […]

Industry Welcomes the European Commission Workshop on the Uptake of Biosimilar Medicines

20 June 2016

The European pharmaceutical industry welcomes the workshop organised today by […]

European Health Ministers Call for More Competition in Pharmaceutical Markets

17 June 2016

Medicines for Europe will engage rapidly with Health Ministers across […]

IGBA Joins ICH and Welcomes the Positive Vote of the General Assembly

15 June 2016

Biosimilar Medicines for Rheumatologists: Bridging the Gap between Regulatory Science and Medical Societies

10 June 2016

Over the past decade, biosimilar medicines have generated more than […]